---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-232117"
form_type: "8-K"
ticker: "ATRA"
cik: "0001604464"
company_name: "Atara Biotherapeutics, Inc."
filed_at: "2025-10-07T23:59:59+00:00"
generated_at: "2026-05-17T04:26:21.577416+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Atara Biotherapeutics cuts ~29% of workforce, retains ~15 employees

## Summary
- Workforce reduction impacts about 29% of current employees; expects to complete by January 2026.
- Approximately $1.3 million in severance and related benefits anticipated.
- Roughly 50% of charges are salary continuation and 60-day notice wages under California WARN Act.
- Company retains about 15 employees for strategic priorities.

## SEC filing metadata
- accession: 0001193125-25-232117
- form_type: 8-K
- ticker: ATRA
- cik: 0001604464
- company_name: Atara Biotherapeutics, Inc.
- filed_at: 2025-10-07T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604464/000119312525232117/0001193125-25-232117-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604464/000119312525232117/d802811d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-232117
- JSON: https://secwatch.observer/filing/0001193125-25-232117.json
- Plain text: https://secwatch.observer/filing/0001193125-25-232117.txt

## Source-grounded claims
- claim_id: 69b30381bb305b536cb9c12ff472d169d9a8cb8b
  claim: Atara Biotherapeutics, Inc. announced a restructuring with charges of $1.3 million (approximately 29% of its current employees).
  evidence_excerpt: to executing on the Company’s strategic priorities. The Company expects to complete the workforce reduction by January 2026. The Company expects to recognize approximately $1.3 million for severance and related benefits for employees laid off under the reduction in force. Approximately fifty percent of these charges are salary continuation payments and wages
  evidence_url: https://www.sec.gov/Archives/edgar/data/1604464/000119312525232117/0001193125-25-232117-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.